Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Ikena Oncology Q4 EPS $(0.41) Beats $(0.43) Estimate, Sales $658.00K Miss $3.14M Estimate

Author: Happy Mohamed | March 12, 2024 08:06am
Ikena Oncology (NASDAQ:IKNA) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.43) by 4.65 percent. This is a 5.13 percent decrease over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $658.00 thousand which missed the analyst consensus estimate of $3.14 million by 79.04 percent. This is a 87.93 percent decrease over sales of $5.45 million the same period last year.

Posted In: IKNA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist